Skip to content

← All developments

Illinois Attorney General · October 13, 2026 · Primary source

October 13, 2026 ATTORNEY GENERAL RAOUL JOINS FTC, COALITION OF STATES IN ASKING FEDERAL COURT TO HOLD MARTIN SHKRELI IN CONTEMPT FOR ALLEGEDLY VIOLATING LIFETIME BAN FROM PHARMACEUTICAL INDUSTRY

Score 60PRIMARYregulatoryState AGIL

Summary

Illinois AG Raoul joined the FTC and six other state AGs in filing a contempt motion in the U.S. District Court for the Southern District of New York, alleging Martin Shkreli violated a 2022 lifetime ban from the pharmaceutical industry by publicly trading stocks in at least 60 pharmaceutical companies and broadcasting investment analysis on social media. The 2022 permanent injunction, issued after Shkreli was found liable for antitrust violations related to Daraprim price increases and generic suppression, prohibits him from holding any ownership interest in or influencing the management of any pharmaceutical company. Sanctions sought include divestiture of all pharmaceutical stocks, forfeiture of trading profits plus interest, and potential incarceration for future violations.

What this may mean

The contempt proceeding targets an individual subject to a permanent injunction and does not directly alter the regulatory obligations of pharmaceutical companies, payors, or providers. However, the enforcement action reinforces that FTC and state AG antitrust oversight of pharmaceutical pricing and market manipulation remains active, and the court's resolution of what constitutes 'participating in the pharmaceutical industry' under the injunction could inform the scope of future industry-bar orders in antitrust settlements.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items